Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...

As SpringWorks Therapeutics nears a key regulatory decision in the U.S., the Connecticut-based cancer and rare disease ...

Big pharma has come under a lot of scrutiny from regulators and consumers as sentiment sours on the industry. As such, the ...

All patients in the trial will have the opportunity to resume or begin treatment with Winrevair, the company said.

BusinessWire India Accra [Ghana] Mumbai Maharashtra [India] January 31 Senator Dr Rasha Kelej CEO of Merck Foundation and ...

India], February 12: Merck Foundation, the philanthropic arm of Merck KGaA Germany, marks 'International Day of Girls and ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the Phase 3 HYPERION study evaluating ...

The healthcare pioneer shares insights on transformative diagnostics where precision medicine meets women’s health innovation ...